Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-16 Sale | 2024-07-17 4:53 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 20,000 | $16.01 | $320,226 | 2,121,081 (Indirect Direct) | View |
| 2024-06-21 Sale | 2024-06-21 7:17 pm | Day One Biopharmaceuticals Inc. | DAWN | Ramasastry Saira Director | 10,000 | $13.19 | $131,877 | 40,485 (Direct) | View |
| 2024-06-10 Sale | 2024-06-12 4:29 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 30,000 | $12.62 | $378,588 | 2,141,081 (Indirect Direct) | View |
| 2024-05-16 Sale | 2024-05-17 6:27 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 7,873 | $16.08 | $126,588 | 1,930,958 (Indirect Direct) | View |
| 2024-05-16 Sale | 2024-05-17 6:18 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 2,267 | $16.08 | $36,450 | 2,277,465 (Indirect Direct) | View |
| 2024-05-16 Sale | 2024-05-17 6:15 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 2,675 | $16.08 | $43,011 | 348,368 (Direct) | View |
| 2024-05-16 Sale | 2024-05-17 6:11 pm | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 3,253 | $16.08 | $52,304 | 120,483 (Direct) | View |
| 2024-05-10 Sale | 2024-05-14 6:13 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 10,000 | $16.37 | $163,743 | 2,164,662 (Indirect Direct) | View |
| 2024-05-01 Sale | 2024-05-03 6:48 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 79,211 | $17.87 | $1,415,707 | 1,686,326 (Indirect Direct) | View |
| 2024-05-01 Sale | 2024-05-03 6:44 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 60,461 | $17.88 | $1,081,191 | 217,293 (Direct) | View |
| 2024-04-18 Sale | 2024-04-22 6:36 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 10,000 | $16.02 | $160,163 | 2,174,662 (Indirect Direct) | View |
| 2024-03-25 Sale | 2024-03-26 6:09 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 10,000 | $16.01 | $160,055 | 2,184,662 (Indirect Direct) | View |
| 2024-03-11 Sale | 2024-03-13 4:24 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 30,000 | $15.24 | $457,314 | 2,194,662 (Indirect Direct) | View |
| 2024-02-27 Sale | 2024-02-28 7:55 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 20,000 | $16.11 | $322,166 | 2,224,662 (Indirect Direct) | View |
| 2024-02-16 Sale | 2024-02-20 6:48 pm | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 3,242 | $15.25 | $49,434 | 123,736 (Direct) | View |
| 2024-02-16 Sale | 2024-02-20 6:36 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 2,666 | $15.25 | $40,651 | 411,504 (Direct) | View |
| 2024-02-16 Sale | 2024-02-20 6:26 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF RESEARCH AND DEVELOPME | 2,258 | $15.25 | $34,430 | 2,359,732 (Indirect Direct) | View |
| 2024-02-16 Sale | 2024-02-20 6:14 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 7,615 | $15.25 | $116,114 | 2,018,042 (Indirect Direct) | View |
| 2023-11-16 Sale | 2023-11-17 6:33 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 956 | $11.69 | $11,176 | 308,170 (Direct) | View |
| 2023-11-16 Sale | 2023-11-17 6:30 pm | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 5,313 | $11.69 | $62,109 | 67,978 (Direct) | View |
| 2023-11-16 Sale | 2023-11-17 6:26 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme | 709 | $11.69 | $8,288 | 2,264,990 (Indirect Direct) | View |
| 2023-11-16 Sale | 2023-11-17 6:20 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 3,107 | $11.69 | $36,321 | 1,838,657 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-02 Gift | 2024-07-05 6:11 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 241,912 | $0 | 896,640 (Indirect) | View |
| 2024-05-23 Option Award | 2024-05-28 6:48 pm | N/A 2034-05-22 | Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director | 32,335 | $0 | 32,335 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 6:44 pm | N/A 2034-05-22 | Day One Biopharmaceuticals Inc. | DAWN | Grossman William Director | 32,335 | $0 | 32,335 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 6:31 pm | N/A 2034-05-22 | Day One Biopharmaceuticals Inc. | DAWN | Ramasastry Saira Director | 32,335 | $0 | 32,335 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 6:27 pm | N/A 2034-05-22 | Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director | 32,335 | $0 | 32,335 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 6:24 pm | N/A 2034-05-22 | Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director | 32,335 | $0 | 32,335 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 6:21 pm | N/A 2034-05-22 | Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director | 32,335 | $0 | 32,335 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 6:17 pm | N/A 2034-05-22 | Day One Biopharmaceuticals Inc. | DAWN | Gladstone Michael Director | 32,335 | $0 | 32,335 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 6:13 pm | N/A 2034-05-22 | Day One Biopharmaceuticals Inc. | DAWN | Dable Habib J Director | 32,335 | $0 | 32,335 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-17 6:27 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 19,999 | $0 | 1,930,958 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-17 6:18 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 8,686 | $0 | 2,277,465 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-17 6:15 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 10,250 | $0 | 348,368 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-17 6:11 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 8,399 | $0 | 120,483 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 6:48 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 8,399 | $0 | 123,736 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 6:36 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 10,250 | $0 | 411,504 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 6:26 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF RESEARCH AND DEVELOPME | 8,686 | $0 | 2,359,732 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 6:14 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 19,999 | $0 | 2,018,042 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 5:22 pm | N/A 2034-01-16 | Day One Biopharmaceuticals Inc. | DAWN | Grossman William Director | 66,660 | $0 | 66,660 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 5:19 pm | N/A 2034-01-16 | Day One Biopharmaceuticals Inc. | DAWN | Dable Habib J Director | 66,660 | $0 | 66,660 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:29 pm | N/A 2034-01-04 | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 268,000 | $0 | 268,000 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:25 pm | N/A 2034-01-04 | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 149,000 | $0 | 149,000 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:22 pm | N/A 2034-01-04 | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme | 245,000 | $0 | 245,000 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:17 pm | N/A 2034-01-04 | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 473,000 | $0 | 473,000 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 6:33 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 3,625 | $0 | 308,170 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 6:30 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 13,600 | $0 | 67,978 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 6:26 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme | 2,624 | $0 | 2,264,990 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 6:20 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 8,312 | $0 | 1,838,657 (Direct) | View |
Ownership | 2023-11-16 8:39 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 0 | $0 | 472,291 (Direct) | View |